There you have it:QUOTING GSK:Sales of flu anti-viral Relenza fell 80% to £57 million, reflecting fewer government orders for stockpiling. Surely Peter Cook cant blame this on poor northern seasonal flu season!!
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status